Carcinoid syndrome: diagnosis and medical management

Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,128 · see citing works

Octreotide

Lamberts, S. W. J., van der Lely, A. J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 996 · see citing works

Receptors for Dopamine and Somatostatin: Formation of Hetero-Oligomers with Enhanced Functional Activity

Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 887 · see citing works

THE CLASSIFICATION OF CARCINOID TUMOURS

Williams, E. M. I. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885 · see citing works

Current Status of Gastrointestinal Carcinoids

Modlin, I. M., Kidd, M. S., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 841 · see citing works

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

LAMBERTS, S. W. J., Krenning, E. P., & Reubi, J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 812 · see citing works

Surgical Treatment of Neuroendocrine Metastases to the Liver

Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 769 · see citing works

Histological Typing of Endocrine Tumours

Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747 · see citing works

Carcinoid Tumors

Kulke, M. H., & Mayer, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401107 · Cited by 743 · see citing works

The diagnosis and medical management of advanced neuroendocrine tumors.

Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674 · see citing works

Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657 · see citing works

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

Öberg, K., Kvols, L. K., Caplin, M. E., Fave, G. D., de Herder, W., Rindi, G., Ruszniewski, P. B., Woltering, E. A., & Wiedenmann, B. J. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577 · see citing works

Karzinoide Tumoren des Dunndarms

Oberndorfer, S. (1907) · Medical Entomology and Zoology · Cited by 565 · see citing works

Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group

Faiss, S., Pape, U., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W. A., Riecken, E. O., & Wiedenmann, B. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 499 · see citing works

Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours

Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B. K., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M. E., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477 · see citing works

The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance

Hofland, L. J., & Lamberts, S. W. J. (2003) · Endocrine Reviews · doi:10.1210/er.2000-0001 · Cited by 476 · see citing works

Karnofsky memorial lecture. An odyssey in the land of small tumors.

Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 474 · see citing works

Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

Rubin, J., Ajani, J. A., Schirmer, W. J., Venook, A. P., Bukowski, R. M., Pommier, R. F., Saltz, L. B., Dandona, P., & Anthony, L. B. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 388 · see citing works

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Kwekkeboom, D. J., Mueller‐Brand, J., Paganelli, G., Anthony, L. B., Pauwels, S. A., Kvols, L. K., O’Dorisio, T. M., Valkema, R., Bodei, L., Chinol, M., et al. (2005) · PubMed · Cited by 371 · see citing works

Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein Hormones

Nobels, F. R. E., Kwekkeboom, D. J., Coopmans, W., Schoenmakers, C. H. H., Lindemans, J. W., de Herder, W. W., Krenning, E. P., Bouillon, R., & Lamberts, S. W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4145 · Cited by 355 · see citing works

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Valkema, R., Pauwels, S. A., Kvols, L. K., Kwekkeboom, D. J., Jamar, F., de Jong, M., Barone, R., Walrand, S., Kooij, P. P. M., Bakker, W. H., et al. (2005) · PubMed · Cited by 332 · see citing works

Carcinoid tumour

Caplin, M. E., Buscombe, J. R., Hilson, A. J. W., Jones, A. L., Watkinson, A. F., & Burroughs, A. K. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02286-7 · Cited by 331 · see citing works

Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

Örlefors, H., Sundin, A., Garske, U., Juhlin, C., Öberg, K., Skogseid, B. M., Långström, B., Bergström, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 327 · see citing works

Ueber den primären Krebs des Ileum nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberculose

Lubarsch, O. (1888) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01966242 · Cited by 306 · see citing works

Effect of Surgery on the Outcome of Midgut Carcinoid Disease with Lymph Node and Liver Metastases

Hellman, P., Lundström, T., Öhrvall, U., Eriksson, B. K., Skogseid, B. M., Öberg, K., Janson, E. T., & Åkerström, G. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6630-z · Cited by 300 · see citing works

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

Anthony, L. B., Woltering, E. A., Espenan, G. D., Cronin, M. D., Maloney, T. J., & McCarthy, K. E. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31769 · Cited by 277 · see citing works

111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial

Virgolini, I. J., Britton, K. E., Buscombe, J. R., Moncayo, R., Paganelli, G., & Riva, P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31565 · Cited by 243 · see citing works

(68)Ga-labeled peptides in tumor imaging.

Maëcke, H. R., Hofmann, M., & Haberkorn, U. (2005) · PubMed · Cited by 242 · see citing works

CARCINOID TUMOURS:

Berge, T., & Linell, F. (1976) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1976.tb00122.x · Cited by 238 · see citing works

Laparoscopic Radiofrequency Ablation of Neuroendocrine Liver Metastases

Berber, E., Flesher, N., & SIPERSTEIN, A. E. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6629-5 · Cited by 237 · see citing works

Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms

Wymenga, A. N. M., Eriksson, B. K., Salmela, P. I., Jacobsen, M. B., Cutsem, E. V., Fiasse, R., Välimäki, M. J., Renstrup, J., de Vries, E. G. E., & Öberg, K. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1111 · Cited by 225 · see citing works

Quality of Life in Patients With Gastroenteropancreatic Tumors Treated With [177Lu-DOTA0,Tyr3]octreotate

Teunissen, J. J. M., Kwekkeboom, D. J., & Krenning, E. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.016 · Cited by 197 · see citing works

Interferon in the Management of Neuroendocrine GEP-Tumors

Öberg, K. (2000) · Digestion · doi:10.1159/000051862 · Cited by 188 · see citing works

Candidates for peptide receptor radiotherapy today and in the future.

Reubi, J. C., Mäcke, H. R., & Krenning, E. P. (2005) · PubMed · Cited by 183 · see citing works

Calcification and fibrosis in mesenteric carcinoid tumor: CT findings and pathologic correlation.

Pantongrag-Brown, L., Buetow, P. C., Carr, N. J., Lichtenstein, J. E., & Buck, J. L. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.164.2.7839976 · Cited by 156 · see citing works

Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide

Ruszniewski, P. B., Ish‐Shalom, S., Wymenga, M., O’Toole, D., Arnold, R., Tomassetti, P., Bax, N., Caplin, M. E., Eriksson, B. K., Gläser, B., et al. (2004) · Neuroendocrinology · doi:10.1159/000082875 · Cited by 154 · see citing works

Lack of Benefit from Cervical Cord Stimulation for Dystonia

Kvols, L. K., Martin, J. K., Marsh, H. W., & Moertel, C. G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131915 · Cited by 146 · see citing works

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.

Balon, H. R., Goldsmith, S. J., Siegel, B. A., Silberstein, E. B., Krenning, E. P., Lang, O., & Donohoe, K. J. (2001) · PubMed · Cited by 140 · see citing works

A CASE OF PRIMARY CARCINOMA OF THE ILEUM.

Ransom, W. (1890) · The Lancet · doi:10.1016/s0140-6736(00)64173-9 · Cited by 121 · see citing works

Somatostatin and somatostatin analogues: diagnostic and therapeutic uses

de Herder, W. W., & Lamberts, S. W. J. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00010 · Cited by 119 · see citing works

Chemotherapy in the Treatment of Neuroendocrine Malignant Tumors

Rougier, P. R., & Mitry, E. (2000) · Digestion · doi:10.1159/000051859 · Cited by 114 · see citing works

Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.

Meijer, W. G., van der Veer, E., Jager, P. L., van der Jagt, E. J., Piers, B. A., Kema, I. P., de Vries, E. G. E., & Willemse, P. H. B. (2003) · PubMed · Cited by 106 · see citing works

Management of midgut carcinoids

Åkerström, G., Hellman, P., Hessman, O., & Osmak, L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20188 · Cited by 102 · see citing works

New somatostatin analogs: will they fulfil old promises?

Lamberts, S., van der Lely, A., & Hofland, L. J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460701 · Cited by 101 · see citing works

Rapid Reversal of Carcinoid Crisis with a Somatostatin Analogue

(1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131916 · Cited by 99 · see citing works

Developments in PET for the detection of endocrine tumours

Eriksson, B., Örlefors, H., Öberg, K., Sundín, A., Bergström, M., & Långström, B. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.001 · Cited by 93 · see citing works

Evaluation of 111In-pentetreotide, 131I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease

Zuetenhorst, J. M., HOEFNAGELl, C. A., Boot, H., Olmos, R. A. V., & Taal, B. G. (2002) · Nuclear Medicine Communications · doi:10.1097/00006231-200208000-00006 · Cited by 69 · see citing works

The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid

Tormey, W. P., & Fitzgerald, R. J. (1995) · Postgraduate Medical Journal · doi:10.1136/pgmj.71.839.542 · Cited by 67 · see citing works

Radioembolization for hepatic metastases

Herba, M. J., & Thirlwell, M. P. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.31672 · Cited by 63 · see citing works

Somatostatin Receptor Scintigraphy in Carcinoids, Gastrinomas and Cushing’s Syndrome

Krenning, E. P., Kwekkeboom, D. J., Oei, H. Y., de Jong, R. J. B., Dop, F. J., de Herder, W. W., Reubi, J. C., & Lamberts, S. W. J. (2009) · Digestion · doi:10.1159/000201202 · Cited by 62 · see citing works

Cytoreductive Surgery in Patients with Advanced-Stage Carcinoid Tumors

Güleç, S. A., Mountcastle, T. S., FREY, D. J., Cundiff, J. D., Mathews, E., Anthony, L. B., O’Leary, J. P., & Boudreaux, J. P. (2002) · The American Surgeon · doi:10.1177/000313480206800803 · Cited by 59 · see citing works

Complications of Midgut Carcinoid Tumors and Carcinoid Syndrome

van der Horst‐Schrivers, A. N. A., Wymenga, A. N. M., Links, T. P., Willemse, P. H. B., Kema, I. P., & de Vries, E. G. E. (2004) · Neuroendocrinology · doi:10.1159/000080737 · Cited by 54 · see citing works

Somatostatin Receptor Scintigraphy in Patients with Carcinoid Tumors

Kwekkeboom, D. J., & Krenning, E. P. (1996) · World Journal of Surgery · doi:10.1007/s002689900024 · Cited by 54 · see citing works

Diagnostic, surgical and medical aspect of the midgut carcinoids

de Vries, H., Verschueren, R. C. J., Willemse, P. H. B., Kema, I. P., & de Vries, E. G. E. (2002) · Cancer Treatment Reviews · doi:10.1053/ctrv.2001.0239 · Cited by 50 · see citing works

Highlights of the biology of endocrine tumours of the gut and pancreas.

Rindi, G., & Bordi, C. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100427 · Cited by 50 · see citing works

A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice

Kiaris, H., Schally, A. V., Nagy, A., Szepesházi, K., Hébert, F., & Halmos, G. B. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00437-8 · Cited by 50 · see citing works

Medical Treatment of Metastasizing Carcinoid Tumors

Arnold, R. (1996) · World Journal of Surgery · doi:10.1007/s002689900031 · Cited by 49 · see citing works

Somatostatin analogue treatment of neuroendocrine tumours

de Herder, W. W., van der Lely, A. J., & Lamberts, S. W. J. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.849.403 · Cited by 49 · see citing works

Ablative Therapies for Liver Metastases of Gastroenteropancreatic Endocrine Tumors

Ruszniewski, P. B., & O’Toole, D. (2004) · Neuroendocrinology · doi:10.1159/000080746 · Cited by 46 · see citing works

Carcinoid tumors: iodine-131 MIBG scintigraphy.

Hanson, M. W., Feldman, J. M., Blinder, R. A., Moore, J. O., & Coleman, R. E. (1989) · Radiology · doi:10.1148/radiology.172.3.2772175 · Cited by 46 · see citing works

Percutaneous Ultrasonography-guided Cutting Biopsy from Liver Metastases of Endocrine Gastrointestinal Tumors

Andersson, T., Eriksson, B. K., Lindgren, P. G., Wilander, E., & Öberg, K. (1987) · Annals of Surgery · doi:10.1097/00000658-198712000-00007 · Cited by 44 · see citing works

Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas.

de Herder, W. W., Krenning, E. P., van Eijck, C. H. J., & Lamberts, S. W. J. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110019 · Cited by 44 · see citing works

Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.

Krenning, E. P., Valkema, R., Kwekkeboom, D. J., de Herder, W. W., van Eijck, C. H. J., de Jong, M., Pauwels, S. A., & Reubi, J. (2005) · PubMed · Cited by 43 · see citing works

Daily Cyclic Changes in the Urinary Excretion of 5-Hydroxyindoleacetic Acid in Patients with Carcinoid Tumors

Zuetenhorst, J. M., Korse, C. M., Bonfrèr, J. M. G., Peter, E., Lamers, C. B. H. W., & Taal, B. G. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032151 · Cited by 43 · see citing works

Catecholamine and serotonin content of foods: Effect on urinary excretion of homovanillic and 5-hydroxyindoleacetic acid

Feldman, J. M., Lee, E. M., & Castleberry, C. A. (1987) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)03237-5 · Cited by 39 · see citing works

Intraoperative tumour detection using 111 In-DTPA- D -Phe 1 -octreotide and a scintillation detector

Benjegård, S. A., Forssell-Aronsson, E. B., Wängberg, B., Skånberg, J., Nilsson, O., & Ahlman, H. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100600 · Cited by 35 · see citing works

Sonographic appearance of primary small bowel carcinoid tumor

Rioux, M., Langis, P., & Naud, F. (1995) · Abdominal Imaging · doi:10.1007/bf00199642 · Cited by 33 · see citing works

Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.

Gibril, F., & Jensen, R. T. (1999) · PubMed · Cited by 31 · see citing works

Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors

de Herder, W. W., & Lamberts, S. W. J. (2003) · Endocrine · doi:10.1385/endo:20:3:285 · Cited by 30 · see citing works

Interventional Treatment of the Carcinoid Syndrome

Ahlman, H. K., Nilsson, O., & Olausson, M. (2004) · Neuroendocrinology · doi:10.1159/000080745 · Cited by 21 · see citing works

CASE REPORT: Metastatic Carcinoid Tumor Discovered by Capsule Endoscopy and Not Detected by Esophagogastroduodenoscopy

Coates, S. W., & DeMarco, D. C. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000026311.62364.0b · Cited by 17 · see citing works

CORRESPONDENCE

Taal, B. G., Zuetenhorst, H. J. M., Olmos, R. A. V., & Hoefnagel, C. A. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2001.1225 · Cited by 15 · see citing works

Ileal carcinoid tumor as a cause of massive lower-GI bleeding: the role of capsule endoscopy

Forner, A., Mata, A., Puig, M., Varela, M., Rodrı́guez, F., Llach, J., Feu, F., Bordas, J. M., & Pique, J. M. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01814-0 · Cited by 14 · see citing works

Adding interferon-α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours

Pape, U.-F., & Wiedenmann, B. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.002 · Cited by 14 · see citing works

Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR

Kvols, L. K., Öberg, K., de Herder, W., Anthony, L. B., Glusman, J. E., Tran, L.-L., & Wiedenmann, B. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.8024 · Cited by 14 · see citing works

Carcinoid-syndrome: recent advances, current status and controversies

Ito, T., Lee, L., & Jensen, R. T. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000376 · Cited by 142 · see citing works

Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study

Strosberg, J., Benson, A. B., Huynh, L. Y., Duh, M. S., Goldman, J. M., Sahai, V., RADEMAKER, A. W., & Kulke, M. H. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0120 · Cited by 109 · see citing works

Management of carcinoid syndrome: a systematic review and meta-analysis

Hofland, J., Herrera-Martínez, A. D., Zandee, W. T., & de Herder, W. W. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0495 · Cited by 87 · see citing works

Carcinoid syndrome and perioperative anesthetic considerations

Mancuso, K. F., Kaye, A. D., Boudreaux, J. P., Fox, C. J., Lang, P. M., Kalarickal, P. L., Gomez, S., & Primeaux, P. J. (2011) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2010.12.009 · Cited by 85 · see citing works

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83 · see citing works

The expanding role of somatostatin analogs in the management of neuroendocrine tumors.

Wolin, E. M. (2012) · Europe PMC (PubMed Central) · Cited by 81 · see citing works

Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome

Clement, D., Ramage, J. K., & Srirajaskanthan, R. (2020) · Journal of Oncology · doi:10.1155/2020/8341426 · Cited by 75 · see citing works

Scintigraphic Imaging of Body Neuroendocrine Tumors

INTENZO, C. M., Jabbour, S., Lin, H. C., Miller, J. L., Kim, S. M., Capuzzi, D. M., & Mitchell, E. P. (2007) · Radiographics · doi:10.1148/rg.275065729 · Cited by 73 · see citing works

Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review

Seymour, N., & Sawh, S. C. (2013) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-012-9879-1 · Cited by 65 · see citing works

Hepatic Arterial Chemoembolization Using Drug-Eluting Beads in Gastrointestinal Neuroendocrine Tumor Metastatic to the Liver

Gaur, S. K., Friese, J. L., Sadow, C. A., Ayyagari, R., Binkert, C. A., Schenker, M. P., Kulke, M. H., & Baum, R. P. (2011) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0122-1 · Cited by 63 · see citing works

Role of Somatostatin Signalling in Neuroendocrine Tumours

Rogoza, O., Megnis, K., Kudrjavceva, M., Geriņa-Bērziņa, A., & Rovīte, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031447 · Cited by 62 · see citing works

Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period

Anthony, L. B., & Vinik, A. I. (2011) · Pancreas · doi:10.1097/mpa.0b013e31821f66b4 · Cited by 44 · see citing works

Skin manifestations of hormone-secreting tumors

Jabbour, S. A. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01369.x · Cited by 33 · see citing works

Hepatic-directed Therapies in Patients with Neuroendocrine Tumors

Kennedy, A. S. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.09.010 · Cited by 34 · see citing works

Nutritional and vitamin status in patients with neuroendocrine neoplasms

Clement, D. S. V. M., Tesselaar, M. E. T., van Leerdam, M. E., Srirajaskanthan, R., & Ramage, J. K. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i10.1171 · Cited by 34 · see citing works

Cutaneous Vascular Disorders Associated with Internal Malignancy

Tal, A. K. E., & Tannous, Z. S. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.08.001 · Cited by 33 · see citing works

Red face revisited: Flushing

İkizoğlu, G. (2014) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2014.02.019 · Cited by 28 · see citing works

Neuroendocrine Tumors

Vinik, A. I., Anthony, L. B., Boudreaux, J. P., Go, V. L. W., O’Dorisio, T. M., Ruszniewski, P. B., & Woltering, E. A. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ea5839 · Cited by 26 · see citing works

Carcinoid Syndrome: Updates and Review of Current Therapy

Oleinikov, K., Avniel-Polak, S., Gross, D. J., & Grozinsky‐Glasberg, S. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0671-0 · Cited by 25 · see citing works

Carcinoid tumor arising in a horseshoe kidney

Rodríguez‐Covarrubias, F., Briseño-Gomez, X. G., Valerio, J. C., Lome‐Maldonado, C., & Gabilondo, F. B. (2006) · International Urology and Nephrology · doi:10.1007/s11255-006-9031-7 · Cited by 25 · see citing works

Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms

Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Papini, E., Angelini, F., Baldelli, R., Berretti, D., Bianchetti, S., Bizzarri, G., et al. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0119-0 · Cited by 22 · see citing works

Using the Right Criteria for MCAS

Gülen, T. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-024-01126-0 · Cited by 20 · see citing works

Skin manifestations of endocrine and neuroendocrine tumors

Leventhal, J. S., & Braverman, I. M. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.02.022 · Cited by 19 · see citing works

Primary Carcinoid Tumor of the Cavernous Sinus

Hood, B., Bray, E. R., Bregy, A., Norenberg, M. D., Weed, D. T., & Morcos, J. J. (2013) · World Neurosurgery · doi:10.1016/j.wneu.2013.06.009 · Cited by 19 · see citing works

Carcinoid tumor of the middle ear: report of a case

Şahan, M., Yıldırım, N., Arslanoğlu, A., Karslıoğlu, Y., & Kazikdasş, K. Ç. (2008) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2007.09.008 · Cited by 17 · see citing works

Serum chromogranin A levels for the diagnosis and follow-up of well-differentiated non-functioning neuroendocrine tumors

Cheng, Y., Sun, Z., Bai, C., Yan, X., Qin, R., Meng, C., & Ying, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4114-7 · Cited by 17 · see citing works

Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells

Herrera-Martínez, A. D., Feelders, R. A., van den Dungen, R., Dogan, F., van Koetsveld, P. M., Castano, J. P., de Herder, W. W., & Hofland, L. J. (2019) · Neuroendocrinology · doi:10.1159/000502200 · Cited by 16 · see citing works

Recent Advances in the Diagnosis and Management of Carcinoid Syndrome

Subash, N., Papali, M. M., Bahadur, K. P., Avanthika, C., Jhaveri, S., Thannir, S., Joshi, M., & Valisekka, S. S. (2021) · Disease-a-Month · doi:10.1016/j.disamonth.2021.101304 · Cited by 13 · see citing works

Biochemical Responses in Symptomatic and Asymptomatic Patients with Neuroendocrine Tumors: Pooled Analysis of Two Phase 3 Trials

Mirakhur, B., Pavel, M. E., Pommier, R. F., Fisher, G. A., Phan, A. T., Massien, C., Liyanage, N., Lowenthal, S. P., & Vinik, A. I. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0296 · Cited by 10 · see citing works

Effective strategies for adequate control of hormonal secretion in functioning neuroendocrine neoplasms

Hofland, J., & de Herder, W. W. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101787 · Cited by 9 · see citing works

State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approach

Jokar, N., Amini, A., Ravanbod, M. R., Barekat, M., Shooli, H., Gholamrezanezhad, A., & Assadi, M. (2021) · Nuclear Medicine Review · doi:10.5603/nmr.2021.0019 · Cited by 8 · see citing works

Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis

Hermans, M. A. W., Stelten, B. M. L., Haak, H. R., de Herder, W. W., & Dercksen, M. W. (2014) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-14-0013 · Cited by 6 · see citing works

Carcinoid tumors: Challenges and considerations during anesthetic management

Bajwa, S. S., Panda, A., & Kaur, G. (2015) · Journal of the Scientific Society · doi:10.4103/0974-5009.165537 · Cited by 5 · see citing works

Does Telotristat Have a Role in Preventing Carcinoid Heart Disease?

Herrera-Martínez, A. D., Fuentes-Fayos, A. C., Sánchez‐Sánchez, R., Montero‐Hidalgo, A. J., Sarmento‐Cabral, A., Gálvez-Moreno, M. Á., Gahete, M. D., & Luque, R. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042036 · Cited by 4 · see citing works

Neuroendocrine Tumors

Feelders, R. A., Hofland, L. J., Kwekkeboom, D. J., Lamberts, S. W. J., & de Herder, W. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-375097-6.10035-6 · Cited by 4 · see citing works

An Overview of Neuroendocrine Tumour Markers

Özaslan, E., Diri, H., Karacan, H., Şimşek, Y., & Bayram, F. (2014) · Endocrinology research and practice. · doi:10.4274/tjem.2422 · Cited by 4 · see citing works

Carcinoid Heart Disease Associated with Primary Ovarian Carcinoid Tumor: A Rare Presentation

Ahmad, R. U., Loke, I. W., Saifullah, F., Zafar, H., & Abbasi, S. H. (2024) · Heart Views · doi:10.4103/heartviews.heartviews_104_23 · Cited by 3 · see citing works

A clinical and echocardiographic case report of carcinoid-related valvular heart disease

Ebrahimi, A. J., Marogil, P., Mering, G. V., & Ahmed, M. I. (2020) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa363 · Cited by 3 · see citing works

Acute Inflammatory Bowel Disease Complicating Chronic Alcoholism and Mimicking Carcinoid Syndrome

Ballo, P., Dattolo, P. C. G., Mangialavori, G., Ferro, G., Fusco, F., Consalvo, M., Chiodi, L., Pizzarelli, F., & Zuppiroli, A. (2012) · Case Reports in Gastroenterology · doi:10.1159/000341588 · Cited by 3 · see citing works

Middle-Ear Neuroendocrine Carcinoma

Subías, J. J. M., Uali, M. E., del Rey, F. J., & del Valle, M. (2014) · Acta Otorrinolaringologica (English Edition) · doi:10.1016/j.otoeng.2014.05.016 · Cited by 3 · see citing works

Management of sub-5 mm rectal carcinoids with lymph node metastases

Toh, J. W. T., Henderson, C., Yabe, T. E., Ong, E., Chapuis, P. H., & Bokey, L. (2014) · Gastroenterology report · doi:10.1093/gastro/gou073 · Cited by 3 · see citing works

The Effect of Delay in Diagnosis in Patients with Neuroendocrine Tumors

Keizer, A. C., Korse, T., Meijer, W. G., & Tesselaar, M. E. T. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije.15.32 · Cited by 3 · see citing works

An unusual cause of hypoxia: getting to the heart of the matter

Hammersley, D. J., Shamsi, A., Zaman, M. M., Berry, P., & Sturridge, L. (2017) · Echo Research and Practice · doi:10.1530/erp-17-0055 · Cited by 3 · see citing works

Approach to the Patient with Diarrhea

Hecht, G. A., Gaspar, J. P., & Malespin, M. H. (2015) · Yamada's Textbook of Gastroenterology · doi:10.1002/9781118512074.ch41 · Cited by 3 · see citing works

Carcinoma neuroendocrino de oído medio

Subías, J. J. M., Uali, M. E., del Rey, F. J., & del Valle, M. (2013) · Acta Otorrinolaringológica Española · doi:10.1016/j.otorri.2012.12.002 · Cited by 2 · see citing works

Sporadic Gastroenteropancreatic Neuroendocrine Tumors

Appetecchia, M., Lauretta, R., Rota, F., & Carlini, M. (2017) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3955-1_4 · Cited by 2 · see citing works

Optimizing the Management of Carcinoid Syndrome to Reduce the Impact of Diarrhea

Rory Randall, C., Bennett, B., Valone, T., & Blue, K. (2019) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2019.10.8.7 · Cited by 2 · see citing works

Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer

Cavalcanti, I. D. L. (2022) · Springer eBooks · doi:10.1007/978-3-031-10839-6_5 · Cited by 1 · see citing works

Primary Hepatic Carcinoid Tumor Presenting Carcinoid Syndrome and Carcinoid Heart Disease

Susumu, S., Matsuo, S., Azuma, T., Obata, S., Ohno, N., & Hayashi, T. (2006) · Nagasaki University's Academic Output SITE (Nagasaki University) · doi:10.11343/amn.51.125 · Cited by 1 · see citing works

Gastro-Enteropancreatic Neuroendocrine Tumor Cell Dynamics in Liver Microvasculature

Goswamee, P., Arunachalam, S., Mehta, S., Nasim, R., Gunning, W. T., & Giovannucci, D. R. (2015) · Microscopy and Microanalysis · doi:10.1017/s1431927615000392 · Cited by 1 · see citing works

Metastatic Gastrointestinal Carcinoid Tumor with Unknown Primary Site

Liang, P. S., & Shaffer, K. (2007) · Radiology Case Reports · doi:10.2484/rcr.v2i3.90 · Cited by 1 · see citing works

Clinical Approaches of Emergencies in Neuroendocrine Tumors

Mertens, G., Carton, S., Verslype, C., & Cutsem, E. V. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0430-9_15 · Cited by 1 · see citing works

Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer

Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-05494-5_17 · Cited by 1 · see citing works

Rarity and review: evidence-based practice for uncommon diseases

Bryson, G. L. (2013) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-013-9908-8 · Cited by 1 · see citing works

Síndrome Carcinoide: Presentación de caso y revisión de la literatura

Barrios, J. H., Morales, D. A. M., Mendoza, M. P., Ramírez, C. A. T., & Valladales‐Restrepo, L. F. (2014) · Revista Médica de Risaralda

Serotonin, cortisol, and stress-related psychopathology: from bench to bed

Tanke, M. A. C. (2009) · University of Groningen research database (University of Groningen / Centre for Information Technology)

ENDOCRINOLOGIC EMERGENCIES IN DERMATOLOGY

Ryan, M. T., Savarese, V. W., & Jabbour, S. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511778339.032

Practical Clinical Pearls

Taylor, R. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7874-5_6

Carcinoid syndrome in neuroendocrine tumors - not easy to recognize

Bjelović, M. (2013) · Acta chirurgica iugoslavica · doi:10.2298/aci1303013b

Skórne markery chorób jelitowych

Roszkiewicz, J., Lange, M., & Nedoszytko, B. (2011) · Forum Medycyny Rodzinnej

Keywords Neuroendocrine tumors Diagnostic work- up Markers Imaging Incidental findings Non- functioning tumors Carcinoid syndrome Gastrinoma

Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Zini, M., Nuova, S. M., Papini, E., Angelini, F., Bianchetti, S., Baldelli, R., et al. (2014)

Sindrome carcinoide. Relato de caso* Carcinoid syndrome. Case report

Tose, A. R. N., Lopes, B. B. D. C., da Motta, L. L., Aarão, N. R., & Vieira, N. F. R. (2011)

Tumor carcinoide na extremidade distal do apêndice no Serviço de Cirurgia da Irmandade Santa Casa de Misericórdia de Porto Alegre Carcinoid tumor in the distal end of the appendix in the General Surgery Unit of ISCMPA

Dias, D. N. F., Weston, A. C., de Barros, E., Bicca, C., & Luzzatto, R. (2010)

Posterior Reversible Encephalopathy Syndrome Due To Carcinoid Crisis Complicating Transarterial Chemoembolization for Metastatic Carcinoid Tumour

Burke, D., Mayette, M., & Begin, A. (2017) · Canadian Journal of General Internal Medicine · doi:10.22374/cjgim.v12i1.165

Síndrome carcinóide – caso clínico

Silva, R., Cristino, A. V., Santos, P., & de Moura, M. C. (2017) · Galicia Clínica · doi:10.22546/43/1046

Asystolie au cours d’une chirurgie pour tumeur de l’intestin grêle: anaphylaxie ou crise carcinoïde

Aissa, I., Benakrout, A., Meziane, M., Bensghir, M., & Lalaoui, S. J. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.30.92.14877

The Role of Platelet Derived Growth Factor Receptor in Neuroendocrine Tumours

Ko, Y. M. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3pk0792t

Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review L'octreotide intraveineux en mega-dose pour le traitement d'une crise carcinoõ ¨de: une revue methodique

Seymour, N., & Sawh, M. C. (2013)

Carcinoid Syndrome

Clement, D., Srirajaskanthan, R., & Caplin, M. E. (2022) · doi:10.1093/med/9780198870197.003.0108

Overview and Pathophysiology of Neuroendocrine Neoplasms

Srirajaskanthan, R., & Rindi, G. (2022) · doi:10.1093/med/9780198870197.003.0106

Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer

Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2022) · Springer eBooks · doi:10.1007/978-3-319-26067-9_17-4

Neuroendocrine Tumor of the Small Intestine in a Patient from the Northern Fluminense Region of the Province of Rio de Janeiro, Brazil

Filho, R. M. F., Machado, E. M., de Campos, I., Manhães, F. C., Ramos, F. P. C., de Matos, A. A. L., Dias, V. E., Norberg, P. R. B. M., & Norberg, A. N. (2023) · Journal of Advances in Medicine and Medical Research · doi:10.9734/jammr/2023/v35i215237

Young Lady with Abdominal Cramps and Difficulty in Breathing: The Shy Bride

Bhat, S. (2025) · Springer eBooks · doi:10.1007/978-981-95-0636-1_16

atualização Carcinoid Syndrome: Diagnosis and Medical Management

van der Lely, A. J., & de Herder, W. W. (2005)

Management of midgut carcinoids

Åkerström, G., Hellman, P., Hessman, O., & Osmak, L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20188 · Cited by 102 · see citing works

Carcinoid tumours

Janson, E. T., & Öberg, K. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90015-9 · Cited by 14 · see citing works

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou, G. C., Lygidakis, N. J., Toubanakis, C., Pavlatos, S., Tseleni‐Balafouta, S., Giannatou, E., Mallas, E., & Safioleas, M. C. (2005) · PubMed · Cited by 64 · see citing works

Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome)

de Herder, W. W. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.05.007 · Cited by 45 · see citing works